1,7-dimethylxanthine has been researched along with Idiopathic Parkinson Disease in 2 studies
1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine half-life was also estimated from salivary concentrations of caffeine at 2 and 5 h post dose." | 1.31 | Parkinson's disease and CYP1A2 activity. ( Forsyth, JT; Grünewald, RA; Lennard, MS; Rostami-Hodjegan, A; Sagar, HJ; Tucker, GT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumura, N | 1 |
| Aoyama, K | 1 |
| Forsyth, JT | 1 |
| Grünewald, RA | 1 |
| Rostami-Hodjegan, A | 1 |
| Lennard, MS | 1 |
| Sagar, HJ | 1 |
| Tucker, GT | 1 |
1 review available for 1,7-dimethylxanthine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Brain; Caffeine; Cysteine; Excitatory Amino Ac | 2023 |
1 other study available for 1,7-dimethylxanthine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Parkinson's disease and CYP1A2 activity.
Topics: Adult; Aged; Aged, 80 and over; Caffeine; Cytochrome P-450 CYP1A2; Female; Humans; Male; Middle Aged | 2000 |